AROAFAroa Biosurgery Ltd.

About Aroa Biosurgery Ltd. (AROAF)

Aroa Biosurgery Ltd. (AROAF) is a Medical Devices company headquartered in Auckland, New Zealand whose shares trade over-the-counter on the Pink tier.

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction.

AROAF key facts

Ticker symbol

AROAF

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Auckland, New Zealand

Estimated market cap

$83.64M (as of May 9, 2025)

Shares outstanding

342,917,000

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

3/31

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with A